1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Thoracic Outlet Syndrome Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Thoracic Outlet Syndrome Market, by Product Type
8.1.1. Pharmacological Treatments
8.1.1.1. Market Revenue and Forecast
8.1.2. Physical Therapy & Rehabilitation Solutions
8.1.2.1. Market Revenue and Forecast
8.1.3. Surgical Intervention Tools & Devices
8.1.3.1. Market Revenue and Forecast
8.1.4. Diagnostic Imaging & Evaluation Tools
8.1.4.1. Market Revenue and Forecast
8.1.5. Supportive & Adjunctive Treatment Devices
8.1.5.1. Market Revenue and Forecast
9.1. Thoracic Outlet Syndrome Market, by Deployment Type
9.1.1. Hospital-Based Treatment Settings
9.1.1.1. Market Revenue and Forecast
9.1.2. Outpatient Clinics / Ambulatory Centers
9.1.2.1. Market Revenue and Forecast
9.1.3. Home-Based & Remote Therapy Programs
9.1.3.1. Market Revenue and Forecast
10.1. Thoracic Outlet Syndrome Market, by Application
10.1.1. Neurogenic Thoracic Outlet Syndrome
10.1.1.1. Market Revenue and Forecast
10.1.2. Venous Thoracic Outlet Syndrome
10.1.2.1. Market Revenue and Forecast
10.1.3. Arterial Thoracic Outlet Syndrome
10.1.3.1. Market Revenue and Forecast
10.1.4. Mixed/Non-specified TOS Conditions
10.1.4.1. Market Revenue and Forecast
11.1. Thoracic Outlet Syndrome Market, by Technology/Mode of Action
11.1.1. Physical Rehabilitation & Manual Therapy Techniques
11.1.1.1. Market Revenue and Forecast
11.1.2. Pharmacological Pain Management
11.1.2.1. Market Revenue and Forecast
11.1.3. Minimally Invasive Surgical Technologies
11.1.3.1. Market Revenue and Forecast
11.1.4. Imaging & Diagnostic Modalities
11.1.4.1. Market Revenue and Forecast
11.1.5. Nerve & Vascular Decompression Tools
11.1.5.1. Market Revenue and Forecast
12.1. Thoracic Outlet Syndrome Market, by End-User
12.1.1. Hospitals & Specialty Care Centers
12.1.1.1. Market Revenue and Forecast
12.1.2. Physiotherapy & Rehabilitation Clinics
12.1.2.1. Market Revenue and Forecast
12.1.3. Outpatient Surgical Centers
12.1.3.1. Market Revenue and Forecast
12.1.4. Diagnostic Imaging Centers
12.1.4.1. Market Revenue and Forecast
12.1.5. Other End-Users
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product Type
13.1.2. Market Revenue and Forecast, by Deployment Type
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by Technology/Mode of Action
13.1.5. Market Revenue and Forecast, by End-User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product Type
13.1.6.2. Market Revenue and Forecast, by Deployment Type
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by Technology/Mode of Action
13.1.6.5. Market Revenue and Forecast, by End-User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product Type
13.1.7.2. Market Revenue and Forecast, by Deployment Type
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by Technology/Mode of Action
13.1.7.5. Market Revenue and Forecast, by End-User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product Type
13.2.2. Market Revenue and Forecast, by Deployment Type
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by Technology/Mode of Action
13.2.5. Market Revenue and Forecast, by End-User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product Type
13.2.6.2. Market Revenue and Forecast, by Deployment Type
13.2.6.3. Market Revenue and Forecast, by Application
13.2.7. Market Revenue and Forecast, by Technology/Mode of Action
13.2.8. Market Revenue and Forecast, by End-User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product Type
13.2.9.2. Market Revenue and Forecast, by Deployment Type
13.2.9.3. Market Revenue and Forecast, by Application
13.2.10. Market Revenue and Forecast, by Technology/Mode of Action
13.2.11. Market Revenue and Forecast, by End-User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product Type
13.2.12.2. Market Revenue and Forecast, by Deployment Type
13.2.12.3. Market Revenue and Forecast, by Application
13.2.12.4. Market Revenue and Forecast, by Technology/Mode of Action
13.2.13. Market Revenue and Forecast, by End-User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product Type
13.2.14.2. Market Revenue and Forecast, by Deployment Type
13.2.14.3. Market Revenue and Forecast, by Application
13.2.14.4. Market Revenue and Forecast, by Technology/Mode of Action
13.2.15. Market Revenue and Forecast, by End-User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product Type
13.3.2. Market Revenue and Forecast, by Deployment Type
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by Technology/Mode of Action
13.3.5. Market Revenue and Forecast, by End-User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product Type
13.3.6.2. Market Revenue and Forecast, by Deployment Type
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by Technology/Mode of Action
13.3.7. Market Revenue and Forecast, by End-User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product Type
13.3.8.2. Market Revenue and Forecast, by Deployment Type
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by Technology/Mode of Action
13.3.9. Market Revenue and Forecast, by End-User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product Type
13.3.10.2. Market Revenue and Forecast, by Deployment Type
13.3.10.3. Market Revenue and Forecast, by Application
13.3.10.4. Market Revenue and Forecast, by Technology/Mode of Action
13.3.10.5. Market Revenue and Forecast, by End-User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product Type
13.3.11.2. Market Revenue and Forecast, by Deployment Type
13.3.11.3. Market Revenue and Forecast, by Application
13.3.11.4. Market Revenue and Forecast, by Technology/Mode of Action
13.3.11.5. Market Revenue and Forecast, by End-User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product Type
13.4.2. Market Revenue and Forecast, by Deployment Type
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by Technology/Mode of Action
13.4.5. Market Revenue and Forecast, by End-User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product Type
13.4.6.2. Market Revenue and Forecast, by Deployment Type
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by Technology/Mode of Action
13.4.7. Market Revenue and Forecast, by End-User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product Type
13.4.8.2. Market Revenue and Forecast, by Deployment Type
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by Technology/Mode of Action
13.4.9. Market Revenue and Forecast, by End-User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product Type
13.4.10.2. Market Revenue and Forecast, by Deployment Type
13.4.10.3. Market Revenue and Forecast, by Application
13.4.10.4. Market Revenue and Forecast, by Technology/Mode of Action
13.4.10.5. Market Revenue and Forecast, by End-User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product Type
13.4.11.2. Market Revenue and Forecast, by Deployment Type
13.4.11.3. Market Revenue and Forecast, by Application
13.4.11.4. Market Revenue and Forecast, by Technology/Mode of Action
13.4.11.5. Market Revenue and Forecast, by End-User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product Type
13.5.2. Market Revenue and Forecast, by Deployment Type
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by Technology/Mode of Action
13.5.5. Market Revenue and Forecast, by End-User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product Type
13.5.6.2. Market Revenue and Forecast, by Deployment Type
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by Technology/Mode of Action
13.5.7. Market Revenue and Forecast, by End-User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product Type
13.5.8.2. Market Revenue and Forecast, by Deployment Type
13.5.8.3. Market Revenue and Forecast, by Application
13.5.8.4. Market Revenue and Forecast, by Technology/Mode of Action
13.5.8.5. Market Revenue and Forecast, by End-User
14.1. Medtronic
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Johnson & Johnson
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Stryker
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Zimmer Biomet
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Abbott
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Boston Scientific
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. B. Braun
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Teleflex
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Terumo Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Cardinal Health
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client